Important Update for Medtronic Diabetes Customers
We’re confident in the reliability of our Paradigm insulin pump platform and its ability to deliver safe and effective therapy for those who need it. However, because the safety of customers like you is our top priority, it is important for Medtronic to communicate these potential issues so that you are aware that they exist and know what to do should you suspect there is an issue. We anticipate that only a small number of products will show signs of damage and need to be returned.
You can find more information, including a copy of the letter you’ll receive this week and answers to key questions, here: www.medtronicdiabetes.com/support/product-updates.
Should you have any additional questions, please don’t hesitate to contact us at 1-888-204-7616.
On behalf of your Medtronic family,
IMPORTANT SAFETY INFORMATION
- Medtronic Diabetes insulin infusion pumps, continuous glucose monitoring systems and associated components are limited to sale by or on the order of a physician and should only be used under the direction of a healthcare professional familiar with the risks associated with the use of these systems.
- Successful operation of the insulin infusion pumps and/or continuous glucose monitoring systems requires adequate vision and hearing to recognize alerts and alarms.
Medtronic Diabetes Insulin Infusion Pumps
- Insulin pump therapy is not recommended for individuals who are unable or unwilling to perform a minimum of four blood glucose tests per day.
- Insulin pumps use rapid-acting insulin. If your insulin delivery is interrupted for any reason, you must be prepared to replace the missed insulin immediately.
Please visit www.medtronicdiabetes.com/importantsafetyinformation for complete safety information.